CGRP antagonist salt

Details for Australian Patent Application No. 2007238896 (hide)

Owner Merck & Co., Inc.

Inventors Belyk, Kevin

Agent Spruson & Ferguson

Pub. Number AU-A-2007238896

PCT Pub. Number WO2007/120592

Priority 60/790,645 10.04.06 US

Filing date 6 April 2007

Wipo publication date 25 October 2007

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/120592 Priority application(s): WO2007/120592

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238897-Anilino-pyrimidine phenyl and benzothiophene analogs

2007238895-Process for the preparation of CGRP antagonist